hydroxyindoleacetic acid has been researched along with Supranuclear Palsy, Progressive in 3 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results of long-term administration of L-threo-3,4-dihydroxyphenylserine (L-DOPS), a synthetic precursor of noradrenaline, in a patient with freezing gait and pure akinesia are reported." | 1.30 | Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy. ( Fujii, S; Hatanaka, Y; Yamamoto, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kaiserova, M | 1 |
| Chudackova, M | 1 |
| Prikrylova Vranova, H | 1 |
| Mensikova, K | 1 |
| Kastelikova, A | 1 |
| Stejskal, D | 1 |
| Kanovsky, P | 1 |
| Yamamoto, M | 2 |
| Fujii, S | 1 |
| Hatanaka, Y | 1 |
| Ujike, H | 1 |
| Kohira, I | 1 |
| Ogasawara, N | 1 |
| Ogawa, N | 1 |
3 other studies available for hydroxyindoleacetic acid and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Topics: Diagnosis, Differential; Humans; Hydroxyindoleacetic Acid; Multiple System Atrophy; Parkinson Diseas | 2021 |
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.
Topics: Antiparkinson Agents; Droxidopa; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; | 1997 |
[CSF monoamine metabolites in patients with progressive supranuclear palsy].
Topics: Aged; Biogenic Monoamines; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxy | 1992 |